BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8503856)

  • 21. Lipoprotein lipase is active as a monomer.
    Beigneux AP; Allan CM; Sandoval NP; Cho GW; Heizer PJ; Jung RS; Stanhope KL; Havel PJ; Birrane G; Meiyappan M; Gill JE; Murakami M; Miyashita K; Nakajima K; Ploug M; Fong LG; Young SG
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6319-6328. PubMed ID: 30850549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free fatty acids do not release lipoprotein lipase from isolated cardiac myocytes or perfused hearts.
    Rodrigues B; Spooner M; Severson DL
    Am J Physiol; 1992 Feb; 262(2 Pt 1):E216-23. PubMed ID: 1539648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin-independent release of lipoprotein lipase activity from perfused rat hearts.
    Bagby GJ
    Biochim Biophys Acta; 1983 Aug; 753(1):47-52. PubMed ID: 6882786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to lipoprotein lipase. Application to perfused heart.
    Schotz MC; Twu JS; Pedersen ME; Chen CH; Garfinkel AS; Borensztajn J
    Biochim Biophys Acta; 1977 Nov; 489(2):214-24. PubMed ID: 922025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-Mr heparin is as potent as conventional heparin in releasing lipoprotein lipase, but is less effective in preventing hepatic clearance of the enzyme.
    Liu GQ; Bengtsson-Olivecrona G; Ostergaard P; Olivecrona T
    Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):747-52. PubMed ID: 1996970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of nordihydroguaiaretic acid on the secretion of lipoprotein lipase.
    Kim SM; Park TW; Park JW
    J Biochem Mol Biol; 2002 Sep; 35(5):518-23. PubMed ID: 12359096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Separation of molecular species of lipoprotein lipase from adipose tissue.
    Garfinkel AS; Schotz MC
    J Lipid Res; 1972 Jan; 13(1):63-8. PubMed ID: 5059200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metabolic "switch" AMPK regulates cardiac heparin-releasable lipoprotein lipase.
    An D; Pulinilkunnil T; Qi D; Ghosh S; Abrahani A; Rodrigues B
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E246-53. PubMed ID: 15328075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac lipoprotein lipase: effects of lipopolysaccharide and tumor necrosis factor.
    Hülsmann WC; Dubelaar ML; De Wit LE; Persoon NL
    Mol Cell Biochem; 1988 Feb; 79(2):137-45. PubMed ID: 3398837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nutritional regulation of binding sites for lipoprotein lipase in rat heart.
    Ruge T; Bergö M; Hultin M; Olivecrona G; Olivecrona T
    Am J Physiol Endocrinol Metab; 2000 Feb; 278(2):E211-8. PubMed ID: 10662704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid preparation of a relatively stable, partially purified lipoprotein lipase from perfused rat heart.
    Brissette L; Noël SP
    Anal Biochem; 1983 Nov; 135(1):197-200. PubMed ID: 6670740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein lipase binding to adipocytes: evidence for the presence of a heparin-sensitive binding protein.
    Sasaki A; Sivaram P; Goldberg IJ
    Am J Physiol; 1993 Dec; 265(6 Pt 1):E880-8. PubMed ID: 8279543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein lipase activity in ischaemic and anoxic myocardium.
    Mochizuki S; Murase T; Yamaoka H; Ishiki M; Tada N; Nagano M
    Basic Res Cardiol; 1987; 82 Suppl 1():45-52. PubMed ID: 3663010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinase activation of heparin-releasable lipoprotein lipase in rat heart.
    Oscai LB; Caruso RA; Palmer WK
    Biochem Biophys Res Commun; 1986 Feb; 135(1):196-200. PubMed ID: 3954770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial binding sites for lipoprotein lipase are not diminished in perfused hearts from diabetic rats.
    Liu L; Severson DL
    Can J Physiol Pharmacol; 1996 Nov; 74(11):1204-9. PubMed ID: 9028578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein lipase release from cardiac myocytes is increased by decavanadate but not insulin.
    Braun JE; Severson DL
    Am J Physiol; 1992 May; 262(5 Pt 1):E663-70. PubMed ID: 1590376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of heparin on the uptake of lipoprotein lipase in rat liver.
    Neuger L; Vilaró S; Lopez-Iglesias C; Gupta J; Olivecrona T; Olivecrona G
    BMC Physiol; 2004 Nov; 4(1):13. PubMed ID: 15544705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-releasable lipoprotein lipase activity is increased in cardiomyocytes after culture.
    Anderson LG; Carroll R; Acharya A; Severson DL
    Can J Physiol Pharmacol; 1998 Feb; 76(2):229-36. PubMed ID: 9635164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Palmitoyl lysophosphatidylcholine mediated mobilization of LPL to the coronary luminal surface requires PKC activation.
    Pulinilkunnil T; An D; Yip P; Chan N; Qi D; Ghosh S; Abrahani A; Rodrigues B
    J Mol Cell Cardiol; 2004 Nov; 37(5):931-8. PubMed ID: 15522270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunocytochemical localization of the functional fraction of lipoprotein lipase in the perfused heart.
    Pedersen ME; Cohen M; Schotz MC
    J Lipid Res; 1983 May; 24(5):512-21. PubMed ID: 6348194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.